NDTDI
   HOME

TheInfoList



OR:

NDTDI is a tricyclic
tryptamine Tryptamine is an indolamine metabolite of the essential amino acid, tryptophan. The chemical structure is defined by an indole ─ a fused benzene and pyrrole ring, and a 2-aminoethyl group at the second carbon (third aromatic atom, with the f ...
derivative which is thought to act as a
serotonin receptor 5-HT receptors, 5-hydroxytryptamine receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems. They mediate both excitatory and inhibitory neur ...
agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue of
LSD Lysergic acid diethylamide (LSD), also known colloquially as acid, is a potent psychedelic drug. Effects typically include intensified thoughts, emotions, and sensory perception. At sufficiently high dosages LSD manifests primarily mental, vi ...
and is reported to retain similar effects, though with many times lower potency. It has been sold as a
designer drug A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. Des ...
since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.


Legality

NDTDI was made illegal in Latvia in March 2017.Par aizlieguma noteikšanu vielai NDTDI un tās saturošiem izstrādājumiem.
/ref>


See also

*
4,5-DHP-DMT 1-(2-Dimethylaminoethyl)dihydropyrano(3,2-e)indole (4,5-DHP-DMT) is a tricyclic tryptamine derivative which acts as a potent and reasonably selective partial agonist for the serotonin receptor 5-HT, with a Ki of 17.0 nM, and moderate selectivit ...
*
Bay R 1531 Bay R 1531 is a tricyclic tryptamine derivative which acts as a selective serotonin receptor 5-HT1A agonist. It was researched unsuccessfully for the treatment of stroke but remains in use for scientific research. See also * 8-OH-DPAT * RDS-1 ...
*
RU-28306 RU-28306 is a tricyclic tryptamine derivative which acts as a serotonin receptor agonist, with selectivity for 5-HT1 and 5-HT2 subtypes. It can be regarded either as a conformationally constrained derivative of DMT, or a structurally simplifi ...
* RU-24,969


References

{{Tryptamines Serotonin receptor agonists